BD is building a new € 165 million manufacturing facility in Zaragoza, Spain to support the continued strong growth of the pre-filled pharmaceuticals business


The new facility will produce drug delivery devices, employing 150 people in 2024 and up to 600 when full operation begins in 2030

MADRID, May 18, 2021 / PRNewswire / – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will raise € 165 million ($ 200 million) High-tech production facility in the city of Zaragoza in the Aragon region of Spainwhich will create up to 600 jobs by 2030.

BD (Becton, Dickinson and Company) Logo (PRNewsfoto / BD (Becton, Dickinson and Company))

BD plans to start construction on the new facility in late 2021, and the new facility will be the fourth manufacturing facility for BD in Spain. The site will initially employ 150 people and cover an area of ​​8,000 square meters. By 2030, up to 600 people are to be employed on an area of ​​30,000 square meters. The new facility will meet high sustainability and eco-efficiency standards and be a fully digital location with the latest intelligent and autonomous technologies, also known as Industry 4.0 solutions.

“BD’s new facility in Zaragoza will produce drug delivery equipment, mainly for pharmaceutical companies supplying the European market with drugs in prefillable syringes such as vaccines and other biological medicines,” said Eric Borin, global president of BD Pharmaceutical Systems. “This new facility will also add the capacity needed to support critical vaccination campaigns such as those currently taking place in response to the COVID-19 pandemic.”

The new website represents part of the $ 1.2 billion Investment over four years in. was announced December 2020 Expand and modernize production capacity and technology for Prefillable Syringes (PFS) and Advanced Drug Delivery Systems (ADDS) as part of BD’s Growth Strategy 2025. The new website also continues BD’s commitment to Spainwhere it started operations more than 40 years ago and currently has three production sites in San Agustín de Guadalix, Fraga and Almaraz. These facilities produce a total of 10 billion medical devices annually and employ 1,500 people. The Fraga plant is an important production site for the manufacture of injection devices for COVID-19 vaccination.

“After this December 2020 Announcing BD’s intention to build a new facility Europe, a detailed location search led to the fact that Zaragoza, Aragon, due to the optimal conditions of the region, the synergies that could be achieved with the BD factory Fraga, as well as the results and the excellent performance of the currently in Spain, “Lourdes López, General Manager of BD in Spain and Portugal, added.

The planned location in Zaragoza is about to complete the administrative procedure.

About BD
BD is one of the largest global medical technology companies in the world, driving the world of health by improving medical discovery, diagnostics, and care. The company supports the heroes at the forefront of healthcare by developing innovative technologies, services, and solutions that advance both clinical therapy for patients and clinical processes for healthcare providers. BD and its 70,000 employees are passionate and committed to improving the safety and efficiency of the clinician’s care process, enabling laboratory scientists to accurately identify disease, and improving researchers’ skills to develop the next generation of diagnostics and therapeutics . BD is present in virtually every country and works with organizations around the world to address some of the toughest global health problems. By working closely with customers, BD can help improve outcomes, reduce costs, increase efficiency, improve safety, and expand access to health care. For more information on BD, please visit or contact us on LinkedIn at and Twitter @BDandCo.



View original content to download multimedia: -Growth-of-pre-filled-drug-delivery-shop-301293097.html

SOURCE BD (Becton, Dickinson and Company)


Comments are closed.